COMBINATION OF RADIONUCLIDE 177LU-PSMA THERAPY WITH PEMBROLIZUMAB IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) Grant uri icon

Overview

Grant awarded by

  • VIC CANCER AGENCY

Sponsor award id

  • TRP16018

Awards

Contributor

Time

Date/time interval

  • 2017 - 2020

Other

Scheme

  • Translational Research Project